Non-vascular Stents Market, by Product Type (Urological Stents, Gastrointestinal Stents, Pulmonary Or Airway Stents, Others) and by Region - Global Trends, and Forecast to 2025

Non-vascular Stents Market – Minimally Invasive Management of a Wide Variety of Circulatory Disorders

Non-vascular stents are a family of devices used for a variety of applications, including esophageal, biliary, colonic, tracheal, and bronchial implantations. Non-vascular stents employs minimally-invasive procedure for implantation. A minimally-invasive procedure offers faster recovery with reduced pain, and shorter hospital stay. Non-vascular stents are increasingly being used in various applications such as in the treatment of pulmonary, urological, and gastrointestinal diseases. The use of these stents is also increasing in the neural and ophthalmic fields.

The global non-vascular stents market was valued at US$ 934.7 million in 2017 and is expected to witness a robust CAGR of 4.7% over the forecast period (2017 - 2025).

Figure 1. Global Non-vascular Stents Market (US$ Mn), by Region, 2017

non-vascular stents market

Source: Coherent Market Insights (2018)

To have a snippet of the report, request Report Sample

Increasing demand for minimally invasive procedures is expected to boost market growth

Increasing demand for minimally invasive procedures is expected to be a major factor driving the growth of the global non-vascular stents market. Non-vascular stents involve small accurate incisions, resulting in relatively smaller and lesser noticeable scars incurred by conventional surgical procedures that compromise on patient safety. Such a procedure is associated with faster recovery time, thus reducing a patient’s hospital stay. Furthermore, reduced hospital stay in turn, is expected to lower the risk of contracting hospital-acquired infections such as bloodstream infection, urinary tract infection, etc. among patients. These factors pose as major drivers boosting growth of the non-vascular stents market.

Increasing prevalence of chronic diseases is expected to drive market growth

Increasing prevalence of gastrointestinal, urological and pulmonary or airway diseases is expected to fuel the demand for non-vascular stents. Conditions such as chronic obstructive pulmonary disease (COPD), central airway obstruction, and asthma demand the use of pulmonary stents, to open up narrowed airways and ease the respiration process. According to WHO, more than three million people die each year from COPDs worldwide and 90% of these deaths in low and middle income countries. Furthermore, in U.S., every year, kidney disorders kills more people than prostate or breast cancer. For instance, in 2013, approximately 47,000 Americans died from kidney disease. Gastrointestinal diseases have been a major problem and cover a wide variety of parts of the system, (i.e. rectum, intestines, duodenum, and esophagus). Generally, these diseases are treated with palliation with the use of non-vascular stents. In recent years, non-vascular stents have been a standard treatment for removing occluding tumors in the gastrointestinal system.

Advancements in technology to accelerate the market growth

Increasing advancements in technology and material is aiding in the development of specially designed stents for used in various indications, is increasing the demand for non-vascular stents in a wide range of applications. For instance, the development of biodegradable polymers and bio-absorbable scaffolds is increasing the use of stents in pulmonary, gastrointestinal, urological, and biliary strictures. Poly capro-lactone, poly acryl amine, and poly lactic acid-glycolic acid are few of the newly designed biodegradable stent materials, which eliminate the need for stent removal. Nitinol is increasingly being utilized in non-vascular self-expandable stents, as it offers super elasticity and therefore is beneficial to the stent placement in difficult segments of an internal tract. However, high costs of non-vascular stents is expected to negatively impact growth of the market.

Major players operating in the global non-vascular stents market include Allium Medical, Boston Scientific, C.R. Bard, ELLA-CS, S.R.O, EndoChoice, Merit Endotek, Taewoong Medical, and Xlumena.

Non-vascular stents are mainly shielded with a polymeric film or membrane to avoid ingrowth of adjacent tissues through stent mesh. Drugs for suppression of hyperplastic malignant or benign tissues can be integrated into polymeric materials. Materials widely used in stent covering include polyurethane, silicon, and expanded polytrafluoroethylene (e-PTFE). Stents in non-vascular applications are a standard treatment for removal of occluding tumors in the gastrointestinal system.

Dynamics

Major factor driving growth of the non-vascular stents market is increasing application of stents in gastrointestinal and glaucoma-related disorders. Rising incidence of urological problems, gastrointestinal diseases, glaucoma, and other conditions, are expected to increase the demand for non-vascular stents. For instance, in the U.S., gastrointestinal hemorrhage was the most common condition leading to hospitalization, with around 500,000 discharges recorded in 2012. Growing prevalence of gastrointestinal cancer is expected be a major factor driving growth of the global non-vascular stents market. Increasing respiratory and gastro-urological morbidities is increasing the demand for non-vascular stents, as these stents help maintain vessel patency. Furthermore, growing demand for minimally invasive procedures, which enable faster recovery, cause less pain, and involve shorter hospital stays, is expected to boost growth of the non-vascular stents market in the near future. Over the recent past, the demand for such stents is witnessing increasing in ophthalmic and neural applications. Both application areas—eyes and the brain—are sensitive to implantation of devices. Non-vascular stents, being a minimally invasive and accurate procedure, is rapidly being adopted for these applications. Smaller stents, known as a micro-stents, are being developed for application in areas related to eyes and the brain.  

Key features of the study:

  • This report provides in-depth analysis of non-vascular stents market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017 – 2025), considering 2016 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategy adopted by the leading players
  • It profiles leading players in the global non-vascular stents market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments and strategies, and future plans
  • Key companies covered as a part of this study include Allium Medical, Boston Scientific, C.R. Bard, ELLA-CS, s.r.o, EndoChoice, Merit Endotek, Taewoong Medical, and Xlumena, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
  • The global non-vascular stents market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the non-vascular stents market

Detailed Segmentation:

  • Global Non-Vascular Stents Market, By Product Type:
    • Urological Stents
    • Gastrointestinal Stents
    • Pulmonary or Airway Stents
    • Others
  • Global Non-Vascular Stents Market, By Region:
    • North America
      • By Product Type:
        • Urological Stents
        • Gastrointestinal Stents
        • Pulmonary or Airway Stents
        • Others
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Product Type:
        • Urological Stents
        • Gastrointestinal Stents
        • Pulmonary or Airway Stents
        • Others
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Product Type:
        • Urological Stents
        • Gastrointestinal Stents
        • Pulmonary or Airway Stents
        • Others
      • By Country:
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Product Type:
        • Urological Stents
        • Gastrointestinal Stents
        • Pulmonary or Airway Stents
        • Others
      • By Country:
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Product Type:
        • Urological Stents
        • Gastrointestinal Stents
        • Pulmonary or Airway Stents
        • Others
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Product Type:
        • Urological Stents
        • Gastrointestinal Stents
        • Pulmonary or Airway Stents
        • Others
      • By Country:
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Allium Medical *
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments
    • Boston Scientific
    • R. Bard
    • ELLA-CS, s.r.o
    • EndoChoice
    • Merit Endotek
    • Taewoong Medical
    • Xlumena, Inc.

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Key Highlights
    • Regulatory Guidelines
    • Reimbursement Scenario
  4. Global Non-vascular Stents Market, By Product Type, 2017 – 2025, (US$ Million)
    • Introduction
      • Market Share Analysis, By Product Type, 2016 and 2025 (%)
      • Y-o-Y Growth Analysis, 2016 – 2025
      • Segment Trends
    • Gastrointestinal Stents
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Million)
    • Pulmonary or Airway Stents
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Million)
    • Urological Stents
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Million)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Million)
  5. Global Non-vascular Stents Market, By Region, 2017 – 2025, (US$ Million)
    • Introduction
      • Market Share Analysis, By Region, 2016 and 2025 (%)
      • Y-o-Y Growth Analysis, For Region, 2016 – 2025
      • Regional Trends
    • North America
      • Market Size and Forecast, By Product Type, 2015 – 2025, (US$ Million)
      • Market Size and Forecast, By Country, 2015 – 2025, (US$ Million)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Product Type, 2015 – 2025, (US$ Million)
      • Market Size and Forecast, By Country, 2015 – 2025, (US$ Million)
      • Regional Trends
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Product Type, 2015 – 2025, (US$ Million)
      • Market Size and Forecast, By Country, 2015 – 2025, (US$ Million)
      • Regional Trends
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Product Type, 2015 – 2025, (US$ Million)
      • Market Size and Forecast, By Country, 2015 – 2025, (US$ Million)
      • Regional Trends
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of APAC
    • Middle East
      • Market Size and Forecast, By Product Type, 2015 – 2025, (US$ Million)
      • Market Size and Forecast, By Country, 2015 – 2025, (US$ Million)
      • Regional Trends
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Product Type, 2015 – 2025, (US$ Million)
      • Market Size and Forecast, By Country, 2015 – 2025, (US$ Million)
      • Regional Trends
        • South Africa
        • Central Africa
        • North Africa
  6. Competitive Landscape
    • Heat Map Analysis
    • Market Share Analysis
    • Company Profiles
      • Allium Medical *
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Key Developments
        • Strategies
      • Boston Scientific
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Key Developments
        • Strategies
      • R. Bard
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Key Developments
        • Strategies
      • ELLA-CS, s.r.o
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Key Developments
        • Strategies
      • EndoChoice
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Key Developments
        • Strategies
      • Merit Endotek
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Key Developments
        • Strategies
      • Taewoong Medical
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Key Developments
        • Strategies
      • Xlumena, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Key Developments
        • Strategies
    • Analyst Views
  7. Section
    • References
    • Research Methodology
    • About Us and Sales Contact

*Browse 35 market data tables and 25 figures on "Global Non-Vascular Stents Market - Global forecast to 2025”.

Research Methodology

Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:

  • Primary Research (Trade Surveys and Experts Interviews)
  • Desk Research
  • Proprietor Data Analytics Model

In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.


Smiley face

Coherent Market Insights desk research is based on a principle set of research techniques:

  • National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.
  • Multinational level desk research: The research team keeps a track of multinational players, global regulatory bodies, global trade associations, and global organization.

Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:

  • Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.
  • Trade association, National and international media and trade press.
  • Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.
  • Scientific journals, and other technical magazines and whitepapers.

Smiley face

Preliminary Data Mining

The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.

Data Standardization:

Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.

Coherent Statistical model

We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:

  • Micro-economic indicators
  • Macro-economic indicators
  • Environmental indicators
  • Socio-political indicators
  • Technology indicators

Data Processing

Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.

Data Validation

This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:

  • It provides first-hand information on the market dynamics, outlook, and growth parameters.
  • Industry experts validates the estimates which helps the company to cement the on-going research study.
  • Primary research includes online surveys, face-to face interviews, and telephonic interviews.

The primary research is conducted with the ecosystem players including, but not limited to:

  • Raw Material Suppliers
  • Manufacturers
  • System Integrators
  • Distributors
  • End-users

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.